Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPipeHawk Regulatory News (PIP)

Share Price Information for PipeHawk (PIP)

Share Price is delayed by 15 minutes
Get Live Data
2.50    0.00 (0.00%)
Bid:
2.00
Ask:
3.00
Spread: 1.00 (50.00%)
Market Cap: £907.82k
PIP Live PriceLast checked at - London Stock Exchange

Intraday PipeHawk Share Chart

Trading Update and Response to COVID-19

14 May 2020 07:00

RNS Number : 8400M
PipeHawk PLC
14 May 2020
 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 ("MAR").

14 May 2020

PipeHawk plc

("PipeHawk", "Company" or the "Group")

Trading Update and Response to COVID-19

As announced on 19 March 2020 in the Company's interim results, PipeHawk started the second half of the 2019/2020 financial year with increasing commercial momentum and a robust orderbook. Until the end of February 2020, the Group had not experienced any material impact on its businesses as a result of the COVID-19 outbreak.

Response to COVID-19

COVID-19 is clearly having a significant impact on most businesses as we all work to come to terms with a new working normal. Working within key manufacturing sectors, PipeHawk's businesses have continued to operate throughout the COVID-19 pandemic. At the outset of the countrywide lockdown, management implemented a number of processes to safeguard colleagues, suppliers and clients across all group activities. Safeguards include implementing working from home wherever practicable, welcoming essential visitors only, moving to a virtual based contact system with clients and suppliers, enhanced cleaning and disinfection routines within the businesses, implementing new goods in processes to ensure deliveries are segregated and delivery personnel prevented from entering facilities as well as actively implementing safe working practices with the use of PPE where appropriate and practising social distancing through keeping two metres apart.

 

Whilst some areas of the Group have expectedly seen a downturn in orders as clients within sectors including building services, automotive, aerospace etc. have temporarily shut down activity, other areas have witnessed healthy order intake. In particular, business within both Adien and Thomson Engineering Design has remained buoyant. Adien has continued to service long-term contracts in the defence, telecoms and electricity supply sectors and has won further business from competitors unable to fulfil start dates in line with client expectations. Since the start of the year, Thomson has been working at full speed and has won a number of new international orders.

 

QM Systems, PipeHawk's main trading entity, has experienced a reduction in order intake over the past two months. However, its sales effort has been focused on areas where industry continues to operate effectively and a number of new and exciting projects are expected to get underway when business starts returning to the new normal. Prior to commencement of the lockdown period, trading at QM Systems was above management's expectations and as such, QM Systems entered the lockdown period with a very healthy orderbook. QM Systems continues to operate effectively in progressing these orders and has been and continues to be busy. Although the Group has witnessed considerable disruption in our supply chain across its companies, through effective management of these challenges as they occur, PipeHawk has been able to avoid this disruption materially impacting operational activities.

 

 

PipeHawk's teams, throughout these unique times, have been excellent. They have embraced the new working practices with a real 'can do' attitude working from home wherever possible. Where their roles are manufacturing based within our factories, staff have continued to work effectively whilst observing social distancing requirements. They continue to address the many obstacles that are presented by this pandemic in a professional and positive manner. It is clear more than ever in these challenging times that PipeHawk possesses the most important thing of all, a motivated, well managed and focused team.

 

 

Outlook

The Group has been able to take advantage of the numerous UK Government backed schemes that provide financial support. Management continue to take steps to protect the business against a deeper than expected recession through the use of the VAT and PAYE/NI deferral schemes and the successful application for a £400,000 CBIL loan, together with very careful stewardship of PipeHawk's cash resources. A number of the Group's staff have been furloughed where appropriate to further protect PipeHawk's cash position and to put the business in the best possible position to return to normal as quickly as possible, and to limit any potential impact as we exit the lockdown and social restrictions.

 

Given the evolving nature of the pandemic and the uncertainty over its length and severity, PipeHawk is working diligently to assess, plan for and mitigate the potential impact on its core markets by using its technical and manufacturing skills to procure other opportunities in the short-term. The Directors believe the fundamentals of the business remain sound and in particular the QM Systems proposition of automating the production process to increase productivity and reduce staff numbers maybe in even greater demand, as it provides solutions to some of the challenges presented by pandemics like COVID-19. The Board is confident in the Group's ability to withstand the current situation, maximise the short-term opportunities and deliver on its long-term growth ambitions. 

Enquiries:

PipeHawk PlcGordon Watt (Chairman)

Tel. No. 01252 338 959

Allenby Capital (Nomad and Broker)David Worlidge/Asha Chotai

Tel. No. 020 3328 5656

 

Notes to Editors

 

For further information on the Company and its subsidiaries, please visit: www.pipehawk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTUOSARRVUVAUR
Date   Source Headline
26th May 20267:00 amRNSProposed disposal of Utsi Electronics Limited
1st May 20267:00 amRNSProposed disposal of Utsi Electronics Limited
15th Apr 20264:53 pmRNSHolding(s) in Company
30th Mar 20267:00 amRNSHalf-year Report
17th Mar 20263:04 pmRNSHolding(s) in Company
13th Mar 20265:33 pmRNSUpdate in relation to Adien Ltd
10th Mar 20264:20 pmRNSHolding(s) in Company
10th Mar 20264:20 pmRNSHolding(s) in Company
9th Mar 202612:36 pmRNSHolding(s) in Company
9th Mar 202612:29 pmRNSUpdate in relation to Adien Ltd
2nd Mar 20267:00 amRNSProposed disposal of Utsi Electronics Limited
24th Dec 20257:00 amRNSSale of Utsi Electronics
18th Dec 202512:12 pmRNSResult of Annual General Meeting
18th Dec 202512:12 pmRNSResult of Annual General Meeting
25th Nov 20257:00 amRNSFinal results for the year ended 30 June 2025
22nd Sep 20257:00 amRNSPassing of Non-Executive Director
14th Mar 20257:00 amRNSHalf-year Report
20th Dec 20247:00 amRNSGrant of options
19th Dec 202412:09 pmRNSResult of Annual General Meeting
19th Dec 20247:00 amRNSAGM Statement & Trading Update
28th Nov 20247:00 amRNSFinal results for the year ended 30 June 2024
26th Sep 20243:56 pmRNSConvertible Unsecured Loan Stock Update
17th Jul 202412:17 pmRNSChange of Registered Office
16th Jul 20247:00 amRNSAppointment of Administrators to QM Systems
12th Jul 20247:00 amRNSUpdate re. QM Systems Limited
11th Jul 202411:15 amRNSHoldings in Company
5th Jul 20247:00 amRNSTrading update in relation to QM Systems Limited
18th Jun 20247:00 amRNSUpdate on partnership with Unipart Rail Limited
23rd May 20247:00 amRNS£1.2 million contract award
17th May 20247:00 amRNS£0.75 million contract award
13th May 20243:33 pmRNSHolding(s) in Company
7th May 20247:00 amRNSHolding(s) in Company
27th Mar 20247:00 amRNSHalf-year Report
29th Jan 20247:00 amRNS£0.7 million contract award with Stannah UK Ltd
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
21st Dec 20233:27 pmRNSResult of AGM
29th Nov 20237:00 amRNSFinal Results for the year ended 30 June 2023
18th Oct 20237:00 amRNS£0.8 million contract award with JVM
6th Jun 20233:38 pmRNSContract award
30th Mar 20237:00 amRNSHalf-year Report
11th Jan 20233:29 pmRNSGrant of Options - replacement
11th Jan 20237:00 amRNSGrant of Options
10th Jan 20237:00 amRNSDirector dealing
22nd Dec 20221:12 pmRNSResult of Annual General Meeting
22nd Dec 20227:00 amRNSAGM Statement
29th Nov 20227:00 amRNSFinal Results for the year ended 30 June 2022
18th Nov 202210:26 amRNSDirectorate Change
20th Oct 20227:00 amRNSFurther update re. Major contract with Ventive
17th Oct 20227:00 amRNSUpate re. Major contract with Ventive Limite
17th Oct 20227:00 amRNSUpdate re. Major contract with Ventive Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.